Key result
Integrated Chinese and Western medicine improves CVD surrogate markers, but hard clinical outcomes remain underreported.
Why the study?
Does integrated Chinese and Western medicine improve outcomes in patients with cardiovascular diseases compared to placebo?
Does integrated Chinese and Western medicine improve outcomes in patients with cardiovascular diseases compared to placebo?
Answers are grounded in this paper and cite their sources.
Integrated Chinese and Western medicine improves surrogate endpoints in cardiovascular diseases, but evidence for hard clinical outcomes remains limited.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2019) studied this question. Integrated Chinese and Western medicine significantly improved surrogate endpoints for hypertension, ASCVD, arrhythmias, and heart failure, but few trials reported hard cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: